Clinical Trials Logo

Clinical Trial Summary

This study will evaluate whether the effect of personalized patient counselling tool, Information-Motivation-Strategy (IMS) based on the results of the Beliefs about Medicines Questionnaire (BMQ) will improve persistence of Enbrel (etanercept) therapy at week 52 in subjects with rheumatoid arthritis over the historical control as estimated by the standard of care.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02346877
Study type Interventional
Source Amgen
Contact
Status Terminated
Phase Phase 4
Start date April 2015
Completion date October 2015